2015
DOI: 10.1016/j.mric.2015.05.012
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic Resonance-Guided Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 77 publications
0
12
0
Order By: Relevance
“…Given the limitations of currently available chemotherapeutic approaches [1], magnetic drug targeting represents an innovative strategy that facilitates selective delivery and retention of various therapeutic agents at specific tissues [2][3][4][5][6][7]. In this approach, the prospective curative agents, bound to magnetic nanoparticles (MNPs) (ferrofluids) capable of responding to external magnetic fields, are effectively carried into the microcirculation of the tumor, thus minimizing drug accumulation in healthy peripheral tissues [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…Given the limitations of currently available chemotherapeutic approaches [1], magnetic drug targeting represents an innovative strategy that facilitates selective delivery and retention of various therapeutic agents at specific tissues [2][3][4][5][6][7]. In this approach, the prospective curative agents, bound to magnetic nanoparticles (MNPs) (ferrofluids) capable of responding to external magnetic fields, are effectively carried into the microcirculation of the tumor, thus minimizing drug accumulation in healthy peripheral tissues [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…4,5 The coagulation threshold temperature of BSA can be adjusted by altering the pH of the phantom, allowing for delineation of regions heated to threshold temperatures relevant to thermal therapy. 6,7 However, precise, quantitative, and volumetric measurement of absolute temperatures using conventional TMPs requires numerous precisely placed thermocouples that may affect heating patterns during ablation, 8 distributed fiber-optic sensing systems, 9,10 or use of magnetic resonance imaging (MRI) thermometry 11,12 that is resourceand time-intensive (∼$600-700/h; MRI suite times >1 h), 13,14 limited in availability, and requires MRI compatible devices. 14 Tissue-mimicking thermochromic phantoms (TMTCPs) are tissue-mimicking materials that possess the ability to change color in response to a change in temperature.…”
Section: Introductionmentioning
confidence: 99%
“…New tools are required to facilitate customisation of therapy based on the specific needs of individual patients. In the drug delivery paradigm, imaging may be used to identify the target and non-target anatomy or for screening, planning, monitoring, and postprocedural assessment of treatment outcome [3].…”
Section: Introductionmentioning
confidence: 99%